New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
Abstract
New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
Review
For citations:
New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation. Rational Pharmacotherapy in Cardiology. 2015;11(5):551-552. (In Russ.)
Views:
499
Email this article 